Cellyan Biotechnology Files Prospectus For $200M Mixed Shelf

Benzinga Newsdesk www.benzinga.com Neutral 93.2%

Neg 0% Neu 93.2% Pos 0%

https://www.sec.gov/Archives/edgar/data/2007702/000121390026068308/ea0294605-f3_cellyan.htm

Comments

No comments yet. Be the first!